We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rare Gut Bacteria Linked to Restless Legs Syndrome

By LabMedica International staff writers
Posted on 18 Jun 2019
One common sleep disorder in which the microbiome may play a role is restless legs syndrome (RLS). More...
While the pathogenesis of RLS is not fully understood, a relative state of brain iron deficiency has been described in patients with RLS and appears to induce changes in several pathways known to be involved in the disease.

RLS is a sensorimotor disorder characterized by a complaint of a strong, nearly irresistible urge to move the limbs that is often accompanied by other uncomfortable sensations. These symptoms begin or worsen during periods of rest or inactivity such as lying down or sitting, are partially or totally relieved by movement such as walking or stretching, and occur exclusively or predominantly in the evening or at night. Small intestine bacterial overgrowth (SIBO) is a condition in which rare gut-residing bacteria are over-represented in the gut.

Scientists at the Stanford Sleep Center (Redwood City, CA, USA) recruited at the center three groups: RLS and low peripheral iron stores of less than 50ng/mL and/or transferrin saturation of less than 18%, RLS and normal peripheral iron stores, and insomnia (control).

Participants completed questionnaires concerning sleep and SIBO symptoms and were sent home with the Fecal Swab Collection and Preservation System fecal collection kit (Norgen Biotek, Thorold, ON, Canada; https://norgenbiotek.com) and a SIBO Home Breath Test Kit, (Mullumbimby, Australia).

Fecal samples are assayed by the University of Minnesota Genomics Center (Minneapolis, MN, USA) with microbial community profiling evaluated by 16S ribosomal RNA (16S rRNA) gene sequencing protocols. SIBO breath samples are evaluated by Aerodiagnostics (Concord, MA, USA) for hydrogen and methane abnormalities.

The investigators reported that seven participants diagnosed with RLS (three men and four women) have thus far completed the protocol. All indicated poor sleep quality (Pittsburgh Sleep Quality Index [PSQI] ≥ 5) and moderate to severe symptoms of RLS (IRLS scores ranging from 13 to 34/40). SIBO was present in all seven participants (100%) whereas general population rates are estimated to be 6% to15%.

Daniel Jin Blum, PhD, DBSM, an adjunct clinical instructor and first author of the study, said, “We've observed extremely high rates of small intestinal bacterial overgrowth in the RLS group. Exploring the relationship between RLS and gut microbial health has the potential to open novel avenues for possible detection, prevention and treatment for RLS and other sleep disorders.” The study was presented on June 9, 2019, at the Annual meeting of the Associated Professional Sleep Societies held in San Antonio, TX, USA.

Related Links:
Stanford Sleep Center
Norgen Biotek
SIBO
University of Minnesota Genomics Center
Aerodiagnostics



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.